Daily Report : Biotech stocks show a historic level of internal selling pressure

Many biotechnology stocks have been sold aggressively in the past few months. Breadth indicators on a custom biotech index shows that internal selling is on par with some of the worst declines in 22 years. There is decent evidence that it's enough to suggest washed-out conditions.

This post is available to SentimenTrader members only.

Log into your account

To view this blog post, you'll need to log into your SentimenTrader account.

Login to your account

Don't have an account?

Sign up to get RISK-FREE access to all of our indicators, models, commentary and award-winning research.

If you've never tried the service before, there is no charge for the first 30 days. Then pay as little as $1.59 per trading day for access to our award-winning research.

Not ready to signup up for a free trial yet?

Signup for our Daily Lite email to receive highlights of our daily report, research and studies.

Follow us on Twitter:

Subscribe to our Youtube Channel:

RSS Feed

Subscribe to the Blog RSS feed